Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed diagnosis (clinical and histological features) of Hailey Hailey or Darier diseases.~* Moderate to very severe lesions located in large folds~* Patient aged 18 ans or more~* Patient with health coverage~* Patient who have signed the consent form~* Patient proficient into filling out the questionnaires.~Exclusion Criteria:~* Hypersensibility to toxin or excipients~* Myastheny~* Deglutition's problems~* Past medical history of dysphagia or aspiration pneumonia~* Pregnancy (positive B-HCG test performed a maxima 72h before) or breastfeeding~* Mental , physical incapacity to fill in the questionnaires~* Guardianship patients~* Skin infections at the inclusion visit~* Application in the last 7 days at the site of injection of local treatments (apart emollients or antiseptics) or injections of botulism toxin or dynamic phototherapy or laser in the last 6 months.~* Systemic treatment with aminosides in the last 15 days~* Inclusion in another study in the last 2 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Botulism Toxin treatment (Type: EXPERIMENTAL): Injection of 50 UI Botulism toxin for the treated zone

Based on this trial design, predict the completion outcome and termination type (if applicable).